Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eton Pharmaceutcials Inc
(NQ:
ETON
)
5.940
+0.030 (+0.51%)
Streaming Delayed Price
Updated: 1:09 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eton Pharmaceutcials Inc
< Previous
1
2
3
4
5
Next >
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
November 02, 2022
From
Eton Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 27, 2022
Gainers
Via
Benzinga
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
October 18, 2022
From
Eton Pharmaceuticals
Via
GlobeNewswire
Recap: Eton Pharmaceuticals Q2 Earnings
August 11, 2022
Eton Pharmaceuticals (NASDAQ:ETON) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Eton Pharma Shares Tick Higher After Offloading Hospital Products
June 24, 2022
Via
Benzinga
Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying
September 26, 2022
The Nasdaq Composite dropped by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Looking Into Eton Pharmaceuticals's Return On Capital Employed
September 07, 2022
According to data from Benzinga Pro, during Q2, Eton Pharmaceuticals's (NASDAQ:ETON) reported sales totaled $7.36 million. Despite a 70.77% increase in earnings, the company posted a loss of $1.56...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 19, 2022
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
July 18, 2022
Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.
Via
Benzinga
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
July 19, 2022
Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.
Via
Benzinga
Eton Pharmaceuticals (ETON) Stock Is Up 10% on FDA Approval
July 18, 2022
Eton Pharmaceuticals (ETON) stock is on the rise Monday as investors react to news of approval from the FDA for Zonisade.
Via
InvestorPlace
Why Eton Pharmaceuticals Stock Is Moving Higher
July 18, 2022
Eton Pharmaceuticals Inc (NASDAQ: ETON) shares are trading higher Monday after the company announced FDA approval of ZONISADE.
Via
Benzinga
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 24, 2022
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 31, 2022
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
Earnings Outlook For Eton Pharmaceuticals
May 11, 2022
Eton Pharmaceuticals (NASDAQ:ETON) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Eton...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2022
The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a...
Via
Benzinga
Eton Pharmaceuticals Names James Gruber Finance Chief
April 11, 2022
Eton Pharmaceuticals Inc (NASDAQ: ETON) has appointed James Gruber as Chief Financial Officer effective immediately. He succeeds Wilson Troutman, who is retiring....
Via
Benzinga
10 Biggest Price Target Changes For Monday
March 22, 2022
Wells Fargo cut the price target on Gilead Sciences, Inc. (NASDAQ: GILD) from $70 to $63. Gilead Sciences shares rose 0.4% to $59.91 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 17, 2022
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million....
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
March 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Earnings Scheduled For March 16, 2022
March 16, 2022
Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million. • Tarena...
Via
Benzinga
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
January 23, 2022
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that...
Via
Talk Markets
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.